Literature DB >> 6696539

Amputation risk factors in concomitant superficial femoral artery and vein injuries.

T J Phifer, A J Gerlock, W A Vekovius, N M Rich, J C McDonald.   

Abstract

Only a small subset of patients with combined superficial femoral artery and vein injuries results in amputation. The importance of the venous component as a risk factor for amputation is uncertain. Ligation vs. reconstruction of venous injuries is controversial. For clarification of these issues, we analyzed retrospectively multiple risk factors for amputation in combined superficial femoral artery and vein injuries in a civilian population. There were 25 patients treated in a 20-year period. Sixteen injuries were caused by small caliber missiles, six by shotgun blasts, and three by knife wounds. Three patients (12%) ultimately underwent amputation. The major risk factor for amputation was method of vascular reconstruction. All three amputations underwent ligation of the superficial femoral vein with arterial reconstruction by placement of a reversed interposition saphenous vein graft (p = 0.0009). None of the remaining 22 patients with salvaged limbs underwent reconstruction by this combination of techniques. Consequently, the authors emphasize the importance of venous reconstruction, particularly in combined injuries with major arterial involvement requiring interposed grafts.

Entities:  

Mesh:

Year:  1984        PMID: 6696539      PMCID: PMC1353339          DOI: 10.1097/00000658-198402000-00018

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  9 in total

1.  Extremity venous ligation: clinical and hemodynamic correlation.

Authors:  C B Wright; R W Hobson; K G Swan; N M Rich
Journal:  Am Surg       Date:  1975-04       Impact factor: 0.688

2.  Venous trauma: successful venous reconstruction remains an interesting challenge.

Authors:  N M Rich; G J Collins; C A Andersen; P T McDonald; J J Ricotta
Journal:  Am J Surg       Date:  1977-08       Impact factor: 2.565

3.  Popliteal artery repair failure: causes and possible prevention.

Authors:  N M Rich; B S Jarstfer; T M Geer
Journal:  J Cardiovasc Surg (Torino)       Date:  1974 May-Jun       Impact factor: 1.888

Review 4.  An experimental and clinical evaluation of grafts in the venous system.

Authors:  H Haimovici; P W Hoffert; N Zinicola; C Steinman
Journal:  Surg Gynecol Obstet       Date:  1970-12

5.  Cross-over vein grafts for iliac and femoral venous occlusion.

Authors:  W A Dale; J Harris
Journal:  Ann Surg       Date:  1968-09       Impact factor: 12.969

6.  Reconstruction of the femoro-popliteal vessels with a double graft (arterial and venous) in severe injury of the limb.

Authors:  R Danza; L Mauro; J Arias; F Danza; J Pravia; E Bonavita; N Berois
Journal:  J Cardiovasc Surg (Torino)       Date:  1970 Jan-Feb       Impact factor: 1.888

7.  Combat wounds of the popliteal artery.

Authors:  J F Gorman
Journal:  Ann Surg       Date:  1968-12       Impact factor: 12.969

8.  Vascular trauma in children and adolescents.

Authors:  J R Navarre; P J Cardillo; J F Gorman; P M Clark; B D Martinez
Journal:  Am J Surg       Date:  1982-02       Impact factor: 2.565

9.  Autogenous venous valve transplantation in the dog.

Authors:  H L Bush; D C Nabseth
Journal:  J Surg Res       Date:  1982-04       Impact factor: 2.192

  9 in total
  3 in total

1.  [Functional results following complicated injuries of the extremities--how can they be improved?].

Authors:  J Dörrler; M Lanta; C Mix; W Burmeister; G Ingianni; H U Steinau; P C Maurer
Journal:  Langenbecks Arch Chir       Date:  1987

2.  Management of vascular trauma.

Authors:  P R Cunningham; M Cushman
Journal:  J Natl Med Assoc       Date:  1987-07       Impact factor: 1.798

3.  The early fate of venous repair after civilian vascular trauma. A clinical, hemodynamic, and venographic assessment.

Authors:  J Meyer; J Walsh; J Schuler; J Barrett; J Durham; J Eldrup-Jorgensen; T Schwarcz; D P Flanigan
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.